BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31420008)

  • 1. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation.
    Fenton CG; Crastin A; Martin CS; Suresh S; Montagna I; Hussain B; Naylor AJ; Jones SW; Hansen MS; Gorvin CM; Price M; Filer A; Cooper MS; Lavery GG; Raza K; Hardy RS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 11β-HSD1 dehydrogenase activity on bone histomorphometry of glucocorticoid-induced osteoporotic male Sprague-Dawley rats.
    Elvy Suhana MR; Farihah HS; Faizah O; Nazrun AS; Norazlina M; Norliza M; Ima-Nirwana S
    Singapore Med J; 2011 Nov; 52(11):786-93. PubMed ID: 22173247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis.
    Hardy RS; Fenton C; Croft AP; Naylor AJ; Begum R; Desanti G; Buckley CD; Lavery G; Cooper MS; Raza K
    J Autoimmun; 2018 Aug; 92():104-113. PubMed ID: 29891135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids.
    Fenton C; Martin C; Jones R; Croft A; Campos J; Naylor AJ; Taylor AE; Chimen M; Cooper M; Lavery GG; Raza K; Hardy RS
    Ann Rheum Dis; 2021 Feb; 80(2):250-260. PubMed ID: 33162397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11β-Hydroxysteroid Dehydrogenase Type 1 Facilitates Osteoporosis by Turning on Osteoclastogenesis through Hippo Signaling.
    Li H; Hu S; Wu R; Zhou H; Zhang K; Li K; Lin W; Shi Q; Chen H; Lv S
    Int J Biol Sci; 2023; 19(11):3628-3639. PubMed ID: 37496992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation.
    Park JS; Bae SJ; Choi SW; Son YH; Park SB; Rhee SD; Kim HY; Jung WH; Kang SK; Ahn JH; Kim SH; Kim KY
    J Mol Endocrinol; 2014 Apr; 52(2):191-202. PubMed ID: 24444497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis.
    Fenton CG; Webster JM; Martin CS; Fareed S; Wehmeyer C; Mackie H; Jones R; Seabright AP; Lewis JW; Lai YC; Goodyear CS; Jones SW; Cooper MS; Lavery GG; Langen R; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):182. PubMed ID: 31370858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.
    Doig CL; Fletcher RS; Morgan SA; McCabe EL; Larner DP; Tomlinson JW; Stewart PM; Philp A; Lavery GG
    Endocrinology; 2017 Jun; 158(6):1964-1976. PubMed ID: 28368470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
    Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
    Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
    J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes: The Role in Hapten-Induced Dermatitis.
    Terao M; Itoi S; Matsumura S; Yang L; Murota H; Katayama I
    Am J Pathol; 2016 Jun; 186(6):1499-510. PubMed ID: 27070821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
    Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis.
    Ramli ES; Suhaimi F; Asri SF; Ahmad F; Soelaiman IN
    J Bone Miner Metab; 2013 May; 31(3):262-73. PubMed ID: 23274351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
    Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
    Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.